BLOG: Having grown up being silenced and marginalised as a gay man, Martin Wells was floored by another societal taboo in later life after being diagnosed with prostate cancer. He tells us how he was driven to find support and why he's delighted by our new online support group for men like him.
More news from the National Cancer Research Institute (NCRI) Cancer Conference this week comes from researchers at the Institute of Cancer Research (ICR) in London. They’ve carried out a large-scale analysis of patient data from another trial to predict which men are most likely to experience unpleasant side effects after radiotherapy.
New research presented at the National Cancer Research Institute (NCRI) Cancer Conference shows men with naturally low levels of testosterone are less likely to develop prostate cancer. But the study has also raised some difficult questions.
Hayley Yarnley knows how much our new precision medicine research programme could have helped her father, Bernie, who died from advanced prostate cancer last December. She describes how the births of her children kept him going during his treatment, and why he was convinced scientists would one day find a cure.
Our new precision medicine research programme aims to tailor treatments based on the genetic make-up of a man’s prostate cancer. The results could extend the lives of more than 9,000 men with advanced disease every year in the UK.
In this guest blog Dr Chris Armstrong – Marcher, Mo grower and ambitious researcher – explains what he hopes to achieve with the Travelling Prize Fellowship we’ve just awarded him and how this critical leg up the academic research ladder will benefit men with prostate cancer.
Nick Butter aims to run a marathon in every country in the world, in a record-breaking 18-month challenge to raise money for Prostate Cancer UK. He tells us his inspiration for doing it and how you can get involved.
The Brighton & Hove Albion boss is the latest top football manager to join our awareness campaign targeting fans. He tells us how he's been affected by prostate cancer and reveals the team talk he's most proud of in his managerial career.
Plans to rollout mpMRI scans before a first biopsy for all UK men suspected of prostate cancer are under threat, as long-term vacancies and increasing demand put a strain on the NHS's radiology services.
Deciding whether 'to treat or not to treat' localised prostate cancer is one of the biggest dilemmas for men and their doctors. Now new research from one of our Centres of Excellence could help identify which cancers are likely to spread and which are harmless.